NO974221L - Indazolkarboksamider - Google Patents

Indazolkarboksamider

Info

Publication number
NO974221L
NO974221L NO974221A NO974221A NO974221L NO 974221 L NO974221 L NO 974221L NO 974221 A NO974221 A NO 974221A NO 974221 A NO974221 A NO 974221A NO 974221 L NO974221 L NO 974221L
Authority
NO
Norway
Prior art keywords
alkyl
phenyl
naphthyl
amino
substituted
Prior art date
Application number
NO974221A
Other languages
English (en)
Other versions
NO974221D0 (no
NO312833B1 (no
Inventor
John T Catlow
Marlene Lois Cohen
Michael John Martinelli
John Mehnert Schaus
Steven P Swanson
Dennis C Thompson
Thomas Michael Wilson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/485,956 external-priority patent/US5654320A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO974221D0 publication Critical patent/NO974221D0/no
Publication of NO974221L publication Critical patent/NO974221L/no
Publication of NO312833B1 publication Critical patent/NO312833B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Paper (AREA)
  • Luminescent Compositions (AREA)
NO19974221A 1995-03-16 1997-09-12 Indazolkarboksamider, fremgangsmåte for fremstilling derav, anvendelse av forbindelsene samt farmasöytiske preparaterinneholdende disse NO312833B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40511995A 1995-03-16 1995-03-16
US08/485,956 US5654320A (en) 1995-03-16 1995-06-07 Indazolecarboxamides
PCT/US1996/003551 WO1996033713A1 (en) 1995-03-16 1996-03-14 Indazolecarboxamides

Publications (3)

Publication Number Publication Date
NO974221D0 NO974221D0 (no) 1997-09-12
NO974221L true NO974221L (no) 1997-10-27
NO312833B1 NO312833B1 (no) 2002-07-08

Family

ID=27018928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974221A NO312833B1 (no) 1995-03-16 1997-09-12 Indazolkarboksamider, fremgangsmåte for fremstilling derav, anvendelse av forbindelsene samt farmasöytiske preparaterinneholdende disse

Country Status (23)

Country Link
US (2) US5817676A (no)
EP (1) EP0732333B1 (no)
JP (1) JPH11502230A (no)
CN (1) CN1112923C (no)
AT (1) ATE203748T1 (no)
AU (1) AU700842B2 (no)
BR (1) BR9608223A (no)
CA (1) CA2215359A1 (no)
DE (1) DE69614164T2 (no)
DK (1) DK0732333T3 (no)
EA (1) EA000699B1 (no)
ES (1) ES2159345T3 (no)
GR (1) GR3037029T3 (no)
HU (1) HU223973B1 (no)
IL (1) IL117438A (no)
NO (1) NO312833B1 (no)
NZ (1) NZ315971A (no)
PL (1) PL183867B1 (no)
PT (1) PT732333E (no)
RO (1) RO119617B1 (no)
SK (1) SK283924B6 (no)
TR (1) TR199700956T1 (no)
WO (1) WO1996033713A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US5914405A (en) * 1997-10-07 1999-06-22 Eli Lilly And Company Process for preparing 3-substituted indazoles
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
NZ509832A (en) * 1998-08-21 2003-11-28 Novartis Ag New oral formulation for 5-HT4 agonists or antagonists
EP1112270B1 (en) 1998-09-10 2007-03-21 F. Hoffmann-La Roche Ag Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
AU2001270304A1 (en) 2000-07-07 2002-01-21 The Administrators Of The Tulane Educational Fund Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
MXPA03001210A (es) * 2000-08-07 2004-08-12 Smithkline Beecham Corp Uso de antagonista del receptor 5-ht4 en la fabricacion de un medicamento para la profilaxis o tratamiento de fibrilacion atrial.
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
US7838518B2 (en) 2002-02-12 2010-11-23 N.V. Organon 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
ITMI20031467A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco attivo nel dolore neuropatico
SE0401969D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Piperidine derivatives
CA2615611C (en) 2005-07-22 2011-09-27 Pfizer Inc. Indazole derivatives
WO2009106980A2 (en) * 2008-02-29 2009-09-03 Pfizer Inc. Indazole derivatives
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145215A (en) * 1961-12-19 1964-08-18 Sterling Drug Inc Indazole derivatives
JP2795460B2 (ja) * 1988-06-20 1998-09-10 協和醗酵工業株式会社 ピラゾロアクリドン誘導体
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
EP0410509A1 (en) * 1989-07-25 1991-01-30 Duphar International Research B.V New substituted 1H-indazole-3-carboxamides
HU211081B (en) * 1990-12-18 1995-10-30 Sandoz Ag Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
EP0600955A1 (en) * 1991-08-20 1994-06-15 Smithkline Beecham Plc 5-ht4 receptor antagonists
US5552398A (en) * 1991-09-12 1996-09-03 Smithkline Beecham P.L.C. Azabicyclic compounds as 5-HT4 receptor antagonists
JPH07507290A (ja) * 1992-05-23 1995-08-10 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 不安症の治療のための医薬
WO1994000113A2 (en) * 1992-06-27 1994-01-06 Smithkline Beecham Plc Medicaments containing 5-ht4 receptor antagonists
MX9305947A (es) * 1992-09-29 1994-06-30 Smithkline Beecham Plc Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
TW251287B (no) * 1993-04-30 1995-07-11 Nissei Co Ltd
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
DE69614164T2 (de) 2002-04-25
NZ315971A (en) 1999-01-28
SK283924B6 (sk) 2004-05-04
US5798367A (en) 1998-08-25
EP0732333A1 (en) 1996-09-18
WO1996033713A1 (en) 1996-10-31
PL322362A1 (en) 1998-01-19
TR199700956T1 (xx) 1998-02-21
SK124297A3 (en) 1998-02-04
EA199700242A1 (ru) 1998-04-30
PT732333E (pt) 2001-11-30
ATE203748T1 (de) 2001-08-15
HU223973B1 (hu) 2005-03-29
CN1183041A (zh) 1998-05-27
IL117438A (en) 2001-12-23
RO119617B1 (ro) 2005-01-28
HUP9801386A3 (en) 2000-03-28
US5817676A (en) 1998-10-06
GR3037029T3 (en) 2002-01-31
AU6894896A (en) 1996-11-18
MX9706967A (es) 1997-11-29
EP0732333B1 (en) 2001-08-01
CN1112923C (zh) 2003-07-02
HUP9801386A2 (hu) 1999-06-28
DE69614164D1 (de) 2001-09-06
DK0732333T3 (da) 2001-10-08
NO974221D0 (no) 1997-09-12
CA2215359A1 (en) 1996-10-31
NO312833B1 (no) 2002-07-08
BR9608223A (pt) 1998-12-29
PL183867B1 (pl) 2002-07-31
AU700842B2 (en) 1999-01-14
JPH11502230A (ja) 1999-02-23
IL117438A0 (en) 1996-07-23
ES2159345T3 (es) 2001-10-01
EA000699B1 (ru) 2000-02-28

Similar Documents

Publication Publication Date Title
DK0732333T3 (da) Indazolcarboxamider
WO2020140005A3 (en) 1 h-pyrrolo[2,3-b]pyridine derivatives and related compounds as bcl-2 inhibitors for the treatment of neoplastic and autoimmune diseases
SE0104332D0 (sv) Therapeutic agents
GB9524157D0 (en) Therapeutic agents
CO5550421A2 (es) Derivados de indol utiles para el tratamiento de enfermeda- des
NO304946B1 (no) Xantinderivat samt dets anvendelse
DE3882614D1 (de) Indol-derivate.
SE0104330D0 (sv) Therapeutic agents
HUP0400343A2 (hu) Ciklopropil-indol-származékok mint szelektív szerotonin-újrafelvétel inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
SE9904176D0 (sv) New use
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
DK391289A (da) Indolderivater
NZ332240A (en) Substituted indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) and are therefor useful for treating inflammatory diseases
AR030563A1 (es) N-[5-[[[5-alquil-2-oxazolil]metil]tio]-2-tiazolil]carboxamidas inhibidoras de cinasas dependientes de la ciclina y composiciones farmaceuticas que las contienen
PE20030332A1 (es) Terapia de combinacion para el tratamiento del cancer
DE69323667T2 (de) 4-substituierte 1,2,4-Triazolderivate
ATE104145T1 (de) 4-substituierten imidazolen zur senkung des intraokularen druckes.
NO920438L (no) N-(aryloksyalkyl)heteroaryl-8-azabicyklo(3.2.1.)oktaner, mellomprodukter og en fremgangsmaate for fremstilling deravsamt anvendelse som medikamenter
TR200200969T2 (tr) Karbonilamino türevlerinin CNS bozukluklarına karşı kullanılması
SE9904177D0 (sv) Novel compounds
ES8705405A1 (es) Procedimiento de preparar nuevos derivados morfolinicos
ES2181387T3 (es) Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central.